Market Research Report

Human Rabies Vaccine (Vero Cell) Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-11607
  • CAT ID : 7
  • Pages : 117
  • Date : Jun 2023
 

The global Human Rabies Vaccine (Vero Cell) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
0.5ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Human Rabies Vaccine (Vero Cell) include Liaoning Chengda, Guangzhou Nuocheng, Ningbo Rong'an, Hualan Bio-vaccine, Sanofi Pasteur SA, Bharat Biotech, Bavarian Nordic, Serum Institute of India Pvt. and Chengdu Kanghua Biology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Rabies is an acute infectious disease caused by rabies virus. There is no effective treatment for rabies clinically. Rabies vaccination after exposure can stimulate the body to produce immunity against rabies virus and prevent rabies.
This report aims to provide a comprehensive presentation of the global market for Human Rabies Vaccine (Vero Cell), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Vaccine (Vero Cell). This report contains market size and forecasts of Human Rabies Vaccine (Vero Cell) in global, including the following market information:
Global Human Rabies Vaccine (Vero Cell) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Rabies Vaccine (Vero Cell) Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Human Rabies Vaccine (Vero Cell) companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Rabies Vaccine (Vero Cell) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Rabies Vaccine (Vero Cell) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Rabies Vaccine (Vero Cell) Market Segment Percentages, by Type, 2022 (%)
0.5ml
1ml
Global Human Rabies Vaccine (Vero Cell) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Rabies Vaccine (Vero Cell) Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Human Rabies Vaccine (Vero Cell) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Rabies Vaccine (Vero Cell) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Rabies Vaccine (Vero Cell) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Rabies Vaccine (Vero Cell) revenues share in global market, 2022 (%)
Key companies Human Rabies Vaccine (Vero Cell) sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Rabies Vaccine (Vero Cell) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Liaoning Chengda
Guangzhou Nuocheng
Ningbo Rong'an
Hualan Bio-vaccine
Sanofi Pasteur SA
Bharat Biotech
Bavarian Nordic
Serum Institute of India Pvt.
Chengdu Kanghua Biology
Changchun Zhuoyi Biology
Dalian Yali Peak
Jilin Huikang Biopharmaceutical Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Rabies Vaccine (Vero Cell), market overview.
Chapter 2: Global Human Rabies Vaccine (Vero Cell) market size in revenue and volume.
Chapter 3: Detailed analysis of Human Rabies Vaccine (Vero Cell) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Rabies Vaccine (Vero Cell) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Rabies Vaccine (Vero Cell) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 Human Rabies Vaccine (Vero Cell) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Rabies Vaccine (Vero Cell) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Rabies Vaccine (Vero Cell) Overall Market Size
2.1 Global Human Rabies Vaccine (Vero Cell) Market Size: 2022 VS 2029
2.2 Global Human Rabies Vaccine (Vero Cell) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Rabies Vaccine (Vero Cell) Sales: 2018-2029
3 Company Landscape
3.1 Top Human Rabies Vaccine (Vero Cell) Players in Global Market
3.2 Top Global Human Rabies Vaccine (Vero Cell) Companies Ranked by Revenue
3.3 Global Human Rabies Vaccine (Vero Cell) Revenue by Companies
3.4 Global Human Rabies Vaccine (Vero Cell) Sales by Companies
3.5 Global Human Rabies Vaccine (Vero Cell) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Rabies Vaccine (Vero Cell) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Rabies Vaccine (Vero Cell) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Rabies Vaccine (Vero Cell) Players in Global Market
3.8.1 List of Global Tier 1 Human Rabies Vaccine (Vero Cell) Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Rabies Vaccine (Vero Cell) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Rabies Vaccine (Vero Cell) Market Size Markets, 2022 & 2029
4.1.2 0.5ml
4.1.3 1ml
4.2 By Type - Global Human Rabies Vaccine (Vero Cell) Revenue & Forecasts
4.2.1 By Type - Global Human Rabies Vaccine (Vero Cell) Revenue, 2018-2023
4.2.2 By Type - Global Human Rabies Vaccine (Vero Cell) Revenue, 2024-2029
4.2.3 By Type - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2018-2029
4.3 By Type - Global Human Rabies Vaccine (Vero Cell) Sales & Forecasts
4.3.1 By Type - Global Human Rabies Vaccine (Vero Cell) Sales, 2018-2023
4.3.2 By Type - Global Human Rabies Vaccine (Vero Cell) Sales, 2024-2029
4.3.3 By Type - Global Human Rabies Vaccine (Vero Cell) Sales Market Share, 2018-2029
4.4 By Type - Global Human Rabies Vaccine (Vero Cell) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Rabies Vaccine (Vero Cell) Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Human Rabies Vaccine (Vero Cell) Revenue & Forecasts
5.2.1 By Application - Global Human Rabies Vaccine (Vero Cell) Revenue, 2018-2023
5.2.2 By Application - Global Human Rabies Vaccine (Vero Cell) Revenue, 2024-2029
5.2.3 By Application - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2018-2029
5.3 By Application - Global Human Rabies Vaccine (Vero Cell) Sales & Forecasts
5.3.1 By Application - Global Human Rabies Vaccine (Vero Cell) Sales, 2018-2023
5.3.2 By Application - Global Human Rabies Vaccine (Vero Cell) Sales, 2024-2029
5.3.3 By Application - Global Human Rabies Vaccine (Vero Cell) Sales Market Share, 2018-2029
5.4 By Application - Global Human Rabies Vaccine (Vero Cell) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Human Rabies Vaccine (Vero Cell) Market Size, 2022 & 2029
6.2 By Region - Global Human Rabies Vaccine (Vero Cell) Revenue & Forecasts
6.2.1 By Region - Global Human Rabies Vaccine (Vero Cell) Revenue, 2018-2023
6.2.2 By Region - Global Human Rabies Vaccine (Vero Cell) Revenue, 2024-2029
6.2.3 By Region - Global Human Rabies Vaccine (Vero Cell) Revenue Market Share, 2018-2029
6.3 By Region - Global Human Rabies Vaccine (Vero Cell) Sales & Forecasts
6.3.1 By Region - Global Human Rabies Vaccine (Vero Cell) Sales, 2018-2023
6.3.2 By Region - Global Human Rabies Vaccine (Vero Cell) Sales, 2024-2029
6.3.3 By Region - Global Human Rabies Vaccine (Vero Cell) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Human Rabies Vaccine (Vero Cell) Revenue, 2018-2029
6.4.2 By Country - North America Human Rabies Vaccine (Vero Cell) Sales, 2018-2029
6.4.3 US Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.4.4 Canada Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.4.5 Mexico Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Human Rabies Vaccine (Vero Cell) Revenue, 2018-2029
6.5.2 By Country - Europe Human Rabies Vaccine (Vero Cell) Sales, 2018-2029
6.5.3 Germany Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.5.4 France Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.5.5 U.K. Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.5.6 Italy Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.5.7 Russia Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.5.8 Nordic Countries Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.5.9 Benelux Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Human Rabies Vaccine (Vero Cell) Revenue, 2018-2029
6.6.2 By Region - Asia Human Rabies Vaccine (Vero Cell) Sales, 2018-2029
6.6.3 China Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.6.4 Japan Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.6.5 South Korea Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.6.6 Southeast Asia Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.6.7 India Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Human Rabies Vaccine (Vero Cell) Revenue, 2018-2029
6.7.2 By Country - South America Human Rabies Vaccine (Vero Cell) Sales, 2018-2029
6.7.3 Brazil Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.7.4 Argentina Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Human Rabies Vaccine (Vero Cell) Sales, 2018-2029
6.8.3 Turkey Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.8.4 Israel Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.8.5 Saudi Arabia Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
6.8.6 UAE Human Rabies Vaccine (Vero Cell) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Liaoning Chengda
7.1.1 Liaoning Chengda Company Summary
7.1.2 Liaoning Chengda Business Overview
7.1.3 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.1.4 Liaoning Chengda Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.1.5 Liaoning Chengda Key News & Latest Developments
7.2 Guangzhou Nuocheng
7.2.1 Guangzhou Nuocheng Company Summary
7.2.2 Guangzhou Nuocheng Business Overview
7.2.3 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.2.4 Guangzhou Nuocheng Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.2.5 Guangzhou Nuocheng Key News & Latest Developments
7.3 Ningbo Rong'an
7.3.1 Ningbo Rong'an Company Summary
7.3.2 Ningbo Rong'an Business Overview
7.3.3 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.3.4 Ningbo Rong'an Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.3.5 Ningbo Rong'an Key News & Latest Developments
7.4 Hualan Bio-vaccine
7.4.1 Hualan Bio-vaccine Company Summary
7.4.2 Hualan Bio-vaccine Business Overview
7.4.3 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.4.4 Hualan Bio-vaccine Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.4.5 Hualan Bio-vaccine Key News & Latest Developments
7.5 Sanofi Pasteur SA
7.5.1 Sanofi Pasteur SA Company Summary
7.5.2 Sanofi Pasteur SA Business Overview
7.5.3 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.5.4 Sanofi Pasteur SA Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Pasteur SA Key News & Latest Developments
7.6 Bharat Biotech
7.6.1 Bharat Biotech Company Summary
7.6.2 Bharat Biotech Business Overview
7.6.3 Bharat Biotech Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.6.4 Bharat Biotech Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.6.5 Bharat Biotech Key News & Latest Developments
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Company Summary
7.7.2 Bavarian Nordic Business Overview
7.7.3 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.7.4 Bavarian Nordic Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.7.5 Bavarian Nordic Key News & Latest Developments
7.8 Serum Institute of India Pvt.
7.8.1 Serum Institute of India Pvt. Company Summary
7.8.2 Serum Institute of India Pvt. Business Overview
7.8.3 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.8.4 Serum Institute of India Pvt. Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.8.5 Serum Institute of India Pvt. Key News & Latest Developments
7.9 Chengdu Kanghua Biology
7.9.1 Chengdu Kanghua Biology Company Summary
7.9.2 Chengdu Kanghua Biology Business Overview
7.9.3 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.9.4 Chengdu Kanghua Biology Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.9.5 Chengdu Kanghua Biology Key News & Latest Developments
7.10 Changchun Zhuoyi Biology
7.10.1 Changchun Zhuoyi Biology Company Summary
7.10.2 Changchun Zhuoyi Biology Business Overview
7.10.3 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.10.4 Changchun Zhuoyi Biology Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.10.5 Changchun Zhuoyi Biology Key News & Latest Developments
7.11 Dalian Yali Peak
7.11.1 Dalian Yali Peak Company Summary
7.11.2 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Business Overview
7.11.3 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.11.4 Dalian Yali Peak Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.11.5 Dalian Yali Peak Key News & Latest Developments
7.12 Jilin Huikang Biopharmaceutical Co., Ltd.
7.12.1 Jilin Huikang Biopharmaceutical Co., Ltd. Company Summary
7.12.2 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Business Overview
7.12.3 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Major Product Offerings
7.12.4 Jilin Huikang Biopharmaceutical Co., Ltd. Human Rabies Vaccine (Vero Cell) Sales and Revenue in Global (2018-2023)
7.12.5 Jilin Huikang Biopharmaceutical Co., Ltd. Key News & Latest Developments
8 Global Human Rabies Vaccine (Vero Cell) Production Capacity, Analysis
8.1 Global Human Rabies Vaccine (Vero Cell) Production Capacity, 2018-2029
8.2 Human Rabies Vaccine (Vero Cell) Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Rabies Vaccine (Vero Cell) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Rabies Vaccine (Vero Cell) Supply Chain Analysis
10.1 Human Rabies Vaccine (Vero Cell) Industry Value Chain
10.2 Human Rabies Vaccine (Vero Cell) Upstream Market
10.3 Human Rabies Vaccine (Vero Cell) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Rabies Vaccine (Vero Cell) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe